A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 9, Issue 419, Pages eaan8848
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-12-07
DOI
10.1126/scitranslmed.aan8848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection
- (2016) Jeffrey M. Jacobson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA
- (2016) Jeffrey M. Jacobson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Therapeutic vaccines and immunological intervention in HIV infection
- (2016) Giuseppe Pantaleo et al. Current Opinion in HIV and AIDS
- No evidence of posttreatment control after early initiation of antiretroviral therapy
- (2015) Sara Gianella et al. AIDS
- The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption
- (2015) Jonathan Z. Li et al. AIDS
- HIV reservoirs as obstacles and opportunities for an HIV cure
- (2015) Tae-Wook Chun et al. NATURE IMMUNOLOGY
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
- (2015) Jonathan D. Fuchs et al. Open Forum Infectious Diseases
- Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load
- (2014) Yves Lévy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
- (2014) Richard B Pollard et al. LANCET INFECTIOUS DISEASES
- Immune Activation with HIV Vaccines
- (2014) A. S. Fauci et al. SCIENCE
- Short-Course Antiretroviral Therapy in Primary HIV Infection
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
- (2013) F. Garcia et al. Science Translational Medicine
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
- (2013) Asier Sáez-Cirión et al. PLoS Pathogens
- HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy
- (2012) Cécile Goujard et al. ANTIVIRAL THERAPY
- Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion
- (2012) Sara Lodi et al. ARCHIVES OF INTERNAL MEDICINE
- OMIP-014: Validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining
- (2012) Stephen C. De Rosa et al. CYTOMETRY PART A
- HIV Incidence Determination in the United States: A Multiassay Approach
- (2012) Oliver Laeyendecker, Ron Brookmeyer, Matthew M. Cousins, Caroline E. Mullis, Jacob Konikoff, Deborah Donnell, Connie Celum, Susan P. Buchbinder, George R. Seage, Gregory D. Kirk, Shruti H. Mehta, Jacquie Astemborski, Lisa P. Jacobson et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 Tat B-cell epitope vaccination was ineffectual in preventing viral rebound after ART cessation
- (2012) Gideon Goldstein et al. Human Vaccines & Immunotherapeutics
- No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial
- (2012) Marlous L. Grijsen et al. PLOS MEDICINE
- A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
- (2011) Jonathan B Angel et al. AIDS
- Long-term Nonprogressive Disease Among Untreated HIV-Infected Individuals
- (2010) Stephen A. Migueles et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein
- (2010) Robert T. Schooley et al. JOURNAL OF INFECTIOUS DISEASES
- Antiretroviral therapy and management of HIV infection
- (2010) Paul A Volberding et al. LANCET
- Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection
- (2010) Eric S. Rosenberg et al. PLoS One
- Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques
- (2008) Lauren A. Hirao et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started